-
-
-
-
-
-
-
Silexion reports preclinical data showing SIL204 reaches pancreatic cancer sites
-
-
-
-
-
-
-
Silexion Therapeutics (SLXN) Unveils Innovative Expanded Development Plan for SIL204
-
-
-
-
-
-
-
Sielox, Inc. (SLXN) Announces Significant New Data from Phase 2 Trial of LODER
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

